: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

Your Kind of Day?

Thu, 05 Nov 2009 19:06:48 GMT

As a rule, I try not to read too terribly much into a "Fed Day" as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on "Fed Days." But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.[More...]

The Dollar-Proof Portfolio

Thu, 05 Nov 2009 17:31:14 GMT

Don't put off this important piece of the financial-planning process.[More...]

What Investors Should Look for In Today’s Fed Statement

Wed, 04 Nov 2009 13:04:24 GMT

In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).[More...]

Are Discount Brokers Shares Worth Owning?

Wed, 04 Nov 2009 01:28:03 GMT

The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&P gain 15%.[More...]

Technology Rises And Buying Facebook

Tue, 03 Nov 2009 16:54:11 GMT

Technology stocks have done well this year. The Technology Select Sector SPDR (XLK) bottomed out in March and by late October was up more than 60%. Tech has performed better than any other sector year-to-date – up 33.7% as of Friday’s close.[More...]

Buffett Gets His Cheque Book Out

Tue, 03 Nov 2009 16:17:34 GMT

Given the slew of positive economic data Monday you might have been forgiven for expecting a decent rebound in risk assets. There was a rebound of sorts in early New York trading, with the Dow up close to 150 points at one stage.[More...]

Five Ways To Ride The Commodities Bull

Tue, 03 Nov 2009 15:21:07 GMT

Commodity prices have faltered in the last couple of weeks, and much of the “smart money” is saying the boom is over. Don’t believe it.[More...]

Nokia Siemens' reorganization could cut 100 jobs in Dallas area

Thu, 05 Nov 2009 00:48:00 GMT

Nov. 4--Nokia Siemens Networks announced a reorganization Tuesday that could mean close to 100 job cuts in the Dallas area.
The telecommunications equipment and services joint venture said the possible cuts are part of a global reorganization designed to slice costs by more than $700 million by the end of 2011.
Nokia Siemens has its North American headquarters in Irving, with about 900 employees in the Dallas area and 64,000 globally.

: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Your Kind of Day?

The Dollar-Proof Portfolio

What Investors Should Look for In Today’s Fed Statement

Are Discount Brokers Shares Worth Owning?

Technology Rises And Buying Facebook

Buffett Gets His Cheque Book Out

Five Ways To Ride The Commodities Bull

Nokia Siemens' reorganization could cut 100 jobs in Dallas area

Generex to Raise $12.25 Million in Registered Direct Offering

Pittsburgh Post-Gazette Heard Off the Street Column

Charleston, S.C., Housing Agencies Buy Efficient Bulbs With Stimulus Money

Energy Giants Set to Capture Desert Heat

Steps to Save Water, Power Pay Off

AME Info, Abu Dhabi, United Arab Emirates, Energy, Oil and Gas Briefs - Mar 31 2009 1:56PM

AME Info, Abu Dhabi, United Arab Emirates, Technology Briefs - Feb 24 2009 2:00PM

Browser: iTunes Replay to Step into Streaming

AME Info, Abu Dhabi, United Arab Emirates, Finance and Economy Briefs - Feb 9 2009 5:00PM

Mentor Capital Cancer Immunotherapy Index Improves at a 320% Annualized Rate for Quarter

RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on MPG, NTT, ASX, NM, BRE and GPI

StockPreacher.Com Issues Trading Outlook for Novadel Pharma Inc.

Mentor Capital Cancer Immunotherapy Index Posts Second 20% Plus Monthly Gain Lead By ImmunoCellular Therapeutics

New Cancer Immunotherapy Index Posts 23% Gains Lead By Mentor Capital, Inc. And Oncothyreon

Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference

Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine

Generex Announces Sales Agreement With McCarthy and Sons Service

Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock

Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza

Form 4 GENEREX BIOTECHNOLOGY For: Oct 19 Filed by: Masterson Nola E (10K)

Form 4 GENEREX BIOTECHNOLOGY For: Jan 12 Filed by: FLETCHER MARK (10K)

Form 4 GENEREX BIOTECHNOLOGY For: Oct 31 Filed by: FLETCHER MARK (10K)

Form 4 GENEREX BIOTECHNOLOGY For: May 27 Filed by: PERRI ROSE C (10K)

Form 4 GENEREX BIOTECHNOLOGY For: May 27 Filed by: GLUSKIN ANNA E (10K)